Neogen Corporation Stock

Equities

NEOG

US6404911066

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 03:11:21 2024-04-19 pm EDT 5-day change 1st Jan Change
11.58 USD -2.89% Intraday chart for Neogen Corporation -6.42% -42.39%
Sales 2024 * 912M Sales 2025 * 938M Capitalization 2.58B
Net income 2024 * -8M Net income 2025 * 2M EV / Sales 2024 * 2.83 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.76 x
P/E ratio 2024 *
-341 x
P/E ratio 2025 *
795 x
Employees 2,640
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.86%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.73%
1 week-8.23%
Current month-24.40%
1 month-20.84%
3 months-29.78%
6 months-22.23%
Current year-40.68%
More quotes
1 week
11.74
Extreme 11.74
12.51
1 month
11.74
Extreme 11.74
15.96
Current year
11.74
Extreme 11.74
20.72
1 year
11.74
Extreme 11.74
24.10
3 years
10.49
Extreme 10.49
48.85
5 years
10.49
Extreme 10.49
48.85
10 years
10.49
Extreme 10.49
48.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 17-07-16
Director of Finance/CFO 54 21-12-31
Compliance Officer 52 21-02-28
Members of the board TitleAgeSince
Director/Board Member 78 11-05-11
Director/Board Member 69 22-09-11
Chairman 68 16-09-30
More insiders
Date Price Change Volume
24-04-19 11.58 -2.89% 1 092 596
24-04-18 11.93 -1.73% 2,889,764
24-04-17 12.14 -0.16% 3,141,074
24-04-16 12.16 +1.25% 2,589,929
24-04-15 12.01 -2.99% 2,983,088

Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT

More quotes
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. Its Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
11.93 USD
Average target price
17 USD
Spread / Average Target
+42.50%
Consensus